- Home
- NRO vs ME Comparison
NRO vs ME Comparison
Compare NRO & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- ME
- Stock Information
- Founded
- NRO 2003
- ME 2006
- Country
- NRO United States
- ME United States
- Employees
- NRO N/A
- ME N/A
- Industry
- NRO Finance/Investors Services
- ME Precision Instruments
- Sector
- NRO Finance
- ME Health Care
- Exchange
- NRO Nasdaq
- ME Nasdaq
- Market Cap
- NRO 173.7M
- ME 168.9M
- IPO Year
- NRO N/A
- ME N/A
- Fundamental
- Price
- NRO $3.99
- ME $0.30
- Analyst Decision
- NRO
- ME Hold
- Analyst Count
- NRO 0
- ME 1
- Target Price
- NRO N/A
- ME $0.47
- AVG Volume (30 Days)
- NRO 239.4K
- ME 2.8M
- Earning Date
- NRO 01-01-0001
- ME 11-06-2024
- Dividend Yield
- NRO 11.41%
- ME N/A
- EPS Growth
- NRO N/A
- ME N/A
- EPS
- NRO N/A
- ME N/A
- Revenue
- NRO N/A
- ME $199,188,000.00
- Revenue This Year
- NRO N/A
- ME $0.05
- Revenue Next Year
- NRO N/A
- ME $17.98
- P/E Ratio
- NRO N/A
- ME N/A
- Revenue Growth
- NRO N/A
- ME N/A
- 52 Week Low
- NRO $2.51
- ME $0.30
- 52 Week High
- NRO $3.45
- ME $1.16
- Technical
- Relative Strength Index (RSI)
- NRO 74.02
- ME 35.07
- Support Level
- NRO $3.80
- ME $0.30
- Resistance Level
- NRO $4.03
- ME $0.32
- Average True Range (ATR)
- NRO 0.06
- ME 0.02
- MACD
- NRO 0.02
- ME 0.00
- Stochastic Oscillator
- NRO 88.46
- ME 5.43
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.